BioNTech SEBNTX
那斯達克 · USD
90.54
+1.00
(+1.12%)
收盤 06/13 03:59 (UTC+8)
盤後
90.79
+0.25
(+0.28%)
06/13 03:59 (UTC+8)
BioNTech SEBNTX
90.54
+1.00
(+1.12%)
財務數據
損益表
- 14.79
- 1.88
- 1.29
- 12.45
- 11.90
- 1.83
- 2.61
- 15.19
- 9.07
- 1.18
- 65.20
- -87.32
- -31.40
- 867.21
- -4.40
- -84.64
- 42.67
- 482.40
- -40.26
- -86.98
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 118,100 | 907,400 | 1,518,900 | 260,800 | 182,800 | 1,190,000 | 1,244,800 | 128,700 | 187,600 | 1,479,000 |
營業成本 | 71,400 | 333,300 | 148,300 | 76,400 | 83,800 | 243,500 | 178,900 | 59,800 | 59,100 | 179,100 |
營業毛利 | 46,700 | 574,100 | 1,370,600 | 184,400 | 99,000 | 946,500 | 1,065,900 | 68,900 | 128,500 | 1,299,900 |
營業費用 | 717,900 | 854,600 | 716,700 | 662,900 | 660,500 | 79,300 | 684,800 | 762,400 | 635,700 | 701,900 |
研發費用 | 557,000 | 505,400 | 564,800 | 509,100 | 525,600 | 611,800 | 550,300 | 584,600 | 507,500 | 577,800 |
推銷及管理費用 | 163,800 | 291,700 | 148,500 | 137,400 | 146,500 | 132,100 | 150,500 | 183,800 | 132,600 | 149,400 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | -2,900 | 57,500 | 3,400 | 16,400 | -11,600 | -664,600 | -16,000 | -6,000 | -4,400 | -2,300 |
營業利益 | -671,200 | -280,500 | 653,900 | -478,500 | -561,500 | 867,200 | 381,100 | -693,500 | -507,200 | 598,000 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 4,000 | - | - | 3,400 | 3,700 | -2,200 | 8,000 | 3,400 | 4,700 | - |
稅前純益 | -568,100 | -227,400 | 24,700 | -402,700 | -445,400 | 301,200 | 158,700 | -805,800 | -331,800 | 663,200 |
所得稅 | -36,200 | 77,600 | 53,400 | -16,100 | -29,600 | 41,700 | -39,400 | 2,000 | -16,700 | 205,300 |
稅後純益 | -531,900 | -305,000 | -28,700 | -386,600 | -415,800 | 259,500 | 198,100 | -807,800 | -315,100 | 457,900 |
基本每股稅後盈餘(元) | -2.10 | -1.25 | -0.12 | -1.60 | -1.73 | 1.08 | 0.82 | -3.36 | -1.31 | - |
稀釋每股稅後盈餘(元) | -2.10 | -1.25 | -0.12 | -1.60 | -1.73 | 1.08 | 0.81 | -3.36 | -1.31 | - |
基本平均股數(千股) | 253285.00 | 244000.00 | 239166.00 | 241625.00 | 240346.00 | 240277.00 | 241585.00 | 240416.00 | 240534.00 | - |
稀釋平均股數(千股) | 253285.00 | 244000.00 | 239166.00 | 241625.00 | 240346.00 | 240277.00 | 244567.00 | 240416.00 | 240534.00 | - |
還原基本每股稅後盈餘(元) | -2.10 | -1.25 | -0.12 | -1.60 | -1.73 | 1.08 | 0.82 | -3.36 | -1.31 | - |
還原稀釋每股稅後盈餘(元) | -2.10 | -1.25 | -0.12 | -1.60 | -1.73 | 1.08 | 0.81 | -3.36 | -1.31 | - |
還原基本平均股數(千股) | 253,285 | 244,000 | 239,166 | 241,625 | 240,346 | 240,277 | 241,585 | 240,416 | 240,534 | - |
還原稀釋平均股數(千股) | 253,285 | 244,000 | 239,166 | 241,625 | 240,346 | 240,277 | 244,567 | 240,416 | 240,534 | - |
EBITDA(千元) | -442,800 | -62,600 | 148,900 | -348,300 | -398,900 | 464,400 | 211,100 | -752,500 | -288,800 | 742,000 |